0000000001216201

AUTHOR

Daniela Drandi

showing 1 related works from this author

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN SPLENIC MARGINAL ZONE LYMPHOMA TRIALS: PRELIMINARY RESULTS FROM BRISMA/IELSG36 PHASE II STU…

2019

Cancer Researchmedicine.medical_specialtyOncologybusiness.industryMedicinePhases of clinical researchHematologyGeneral MedicineSplenic marginal zone lymphomaRadiologybusinessmedicine.diseaseMinimal residual diseaseHematological Oncology
researchProduct